Your Article Summary
Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in Patients with Chronic Constipation
Forest Laboratories, 11/04/09
Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. announced positive top–line results from two Phase 3 clinical trials assessing the safety and efficacy of once–daily dosing of the investigational drug linaclotide in patients with chronic constipation (CC).
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09
Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials
PharmacoEconomics, 11/24/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Innovative polyurethane spray systems for district cooling
BayNews International, 11/24/09
Pandemic 2009 Influenza Update: Pandemrix data in children and adolescents from 3 to 17 years of age
GlaxoSmithKline, 11/24/09
Prodesse's ProFlu-ST Assay Receives European CE Mark
Gen-Probe, 11/24/09
Article Search
Sponsor


See All


